DIA
LAB icon

Denver Investment Advisors’s Standard BioTools LAB Stock Holding History

Denver Investment Advisors’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-36,085
Closed -$1.59M – 632
2014
Q1 		$1.59M Sell
36,085
-53,111
-60% -$2.34M 0.05% 330
2013
Q4 		$3.42K Sell
89,196
-97,198
-52% -$2.86M 0.1% 238
2013
Q3 		$4.09M Buy
186,394
+62,331
+50% +$1.22M 0.09% 254
2013
Q2 		$2.17M Buy
+124,063
New +$2.18M 0.05% 313

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Denver Investment Advisors's LAB Position: Q2 2014 in Review

Denver Investment Advisors sold out of Standard BioTools (LAB) in Q2 2014, closing a stake of 36,085 shares — an estimated $1.59M sold.

Denver Investment Advisors first reported a position in LAB in Q2 2013 and held it in 4 quarters. The position peaked at $4.09M in Q3 2013. 104 funds tracked by Wall St. Rank hold LAB as of Q2 2014.

  • Denver Investment Advisors reported no remaining Standard BioTools position as of Q2 2014 after selling out during the quarter.
  • Denver Investment Advisors sold 36,085 Standard BioTools shares in Q2 2014, an estimated $1.59M.
  • Denver Investment Advisors first reported a position in Standard BioTools in Q2 2013 and held it in 4 quarters.
  • Denver Investment Advisors's Standard BioTools position peaked at $4.09M in Q3 2013.
  • 104 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2014.

Based on Denver Investment Advisors's 13F filing for Q2 2014, filed 8 Aug 2014.